DCA Officials Seize ‘Colinol-Spas Tab’ For Misleading Claim

HYDERABAD: Officials of Drugs Control Administration, Telangana seized ‘Colinol-SPAS Tablets (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP)’, an allopathic medicine, in Nampally, Hyderabad, for making a misleading advertisement claiming it treats ‘disorders of menstrual flow’.

According to DCA Director-General VB Kamalasan Reddy here on Wednesday, the officials detected a medicine ‘Colinol-SPAS Tablets’ being circulating in the market with misleading claim on its label that it treats ‘disorders of menstrual flow’, which is a contravention of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 prohibits advertisement of certain drugs for treatment of certain diseases and disorders. No person shall take part in publication of advertisement regarding the diseases/disorders indicated under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.

During the special raids conducted on 30th April and 1st May, officials from the Drugs Control Administration, Hyderabad Zone, detected ‘Colinol-SPAS Tablets’ (Mefenamic Acid and Dicyclomine Hydrochloride Tablets IP) Manufactured and Marketed by: Vivimed Labs Ltd., Plot No. 25, Kundeshwari Village, Kashipur- 244713, Uttarakhand. The label of the product bears a misleading claim stating that it is indicated for the treatment of ‘spasmodic dysmenorrhea, menstrual disorders.’

The advertisement of a medicine for the treatment of ‘disorders of menstrual flow’ is prohibited under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. P. Santosh, Drugs Inspector, Mehdipatnam and V. Ajay, Drugs Inspector, Goshamahal are among the officers who carried out the raid. Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

The public may report any complaints regarding illegal activities concerning medicines through the Drugs Control Administration, Telangana Toll-Free Number 1800-599-6969, which is operational from 10:30 am to 5:00 pm on all working days.

Related Posts

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

The Bombay High Court (Nagpur Bench) last week expressed serious concern over repeated and systemic lapses by officers of the Drugs Department in adhering to the mandatory timelines prescribed under…

UP plans US FDA-accredited medical device testing lab

Lucknow:  In a major push to strengthen India’s medical device and pharmaceutical manufacturing ecosystem, the Uttar Pradesh govt is working on an ambitious project to establish a US FDA-accredited medical…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

Drugs & Cosmetics Rules | 60-Day Sample Testing Mandatory; Web-Host Reports: Bombay HC Orders Strict Action Against Erring Officers

UP plans US FDA-accredited medical device testing lab

UP plans US FDA-accredited medical device testing lab

Patent rejected for MNC’s cancer drug, generics to follow

Patent rejected for MNC’s cancer drug, generics to follow

Zydus brings world’s first Nivolumab biosimilar to India

Zydus brings world’s first Nivolumab biosimilar to India

Dr Reddy’s set to start selling generic Ozempic in India at potentially half price

Dr Reddy’s set to start selling generic Ozempic in India at potentially half price

A total of 167 drug samples flagged as ‘not of standard quality’ in December 2025: Health Ministry

A total of 167 drug samples flagged as ‘not of standard quality’ in December 2025: Health Ministry